Please use this identifier to cite or link to this item: http://hdl.handle.net/2123/8688

Title: Studies of the Ubiquitin-NFκβ pathway in women and baboons with endometriosis
Authors: Reyftmann, Romina
Keywords: Endometriosis
Baboon
Ubiquitin
Nuclear factor-kappa beta
I kappa B kinase
Issue Date: 2-Oct-2012
Publisher: Faculty of Medicine
Abstract: Background: Our aim was to determine if changes in ubiquitin are correlated with proteins known to be affected directly or indirectly by the ubiquitin-proteasome pathway. For example, the intermediary kinase of the NFκβ pathway IKK is tagged directly by ubiquitin, aiding its degradation within the large, self-compartmentalised protease called the 26S proteasome. IKK degradation allows the release of NFκβ (an indirect consequence of ubiquitination) that then translocates into the nucleus to initiate the transcription of survival factors such as cIAP2, BCL-XL, BFL1, FLIP, IL-8, and TNF-α. Methods: Lyophilised baboon endometrial tissues from the University of Illinois at Chicago (UIC) and from women undergoing laparoscopy from the Sydney South West Area of Health Service (SSWAHS) were processed for RNA extraction and analysis. Immunohistochemical studies were also conducted on formalin fixed baboon and human endometrial tissues from UIC and from the Sydney West Area Health Service (SWAHS). Results: IKKα immunostaining were elevated in the cytoplasm of glands during late follicular phase and stromal cells during menses in the baboon, whilst proteasome was elevated in the nucleus of glands and stroma at menses, as well as within the glandular cytoplasm of endometriotic tissues. Comparable levels of Iκβα exists throughout the menstrual cycle of the eutopic endometrium, whilst a reduced glandular nuclear Iκβα was seen in endometriotic tissues of the animal model. TNF-α was increased within stromal cells at menses but was equivalent between the eutopic and ectopic endometrium. Ubiquitin was similar between LF and mid luteal phase of eutopic glands and stroma, as well as between eutopic and ectopic endometrium at mid luteal. IKKβ and NFκβ levels were alike within eutopic and ectopic tissues throughout the menstrual cycle. In women however, IKKα, IKKβ, Iκβα and NFκβ had comparable levels within all cell types and cycle phases, whilst a greater proteasome immunostaining was seen in the nucleus of eutopic stromal cells at secretory phase, as well as in the nucleus of ectopic stromal cells at proliferative phase. However, the nucleus of stromal cells and glandular cytoplasm of endometriotic tissues both had lower proteasome levels during the secretory phase. Conclusions: In this study, IKKα had a greater potential to activate the p65 subunit of NFκβ in ectopic stromal cells than IKKβ and TNF-α did not seem to be correlated with greater free ubiquitin expression in endometriosis in the baboon. This suggests that IKKα is a likely candidate for ectopic stromal cell survival in endometriosis in the animal model but this is unlikely to be mediated by the ubiquitin NFκβ pathway. Similarly, in women with endometriosis a different pathway to NFκβ is potentially responsible for a greater ectopic cell survival potential, however an increased patient cohort is required to definitively ascertain the involvement of IKKα in the future.
Description: Doctor of Philosophy (PhD)
URI: http://hdl.handle.net/2123/8688
Appears in Collections:Sydney Digital Theses (Open Access)

Files in This Item:

File Description SizeFormat
Thesis Structure Introd & Abbrev 2012.pdfThesis Structure; Introduction & Abbreviations 2012612.98 kBAdobe PDFView/Open
TABLE OF CONTENTS.pdfTable of contents202.21 kBAdobe PDFView/Open
Chapter 1.pdfLiterature review1.68 MBAdobe PDFView/Open
Chapter 2.pdfMaterials and methods2.17 MBAdobe PDFView/Open
Chapter 3.pdfMolecular studies of human endometrial tissues510.69 kBAdobe PDFView/Open
Chapter 4.pdfMolecular studies of baboon endometrial tissues387.26 kBAdobe PDFView/Open
Chapter 5.pdfImmunohistochemical study of eutopic baboon endometrial tissues139.14 kBAdobe PDFView/Open
Chapter 6.pdfImmunohistochemical study of ectopic baboon endometrial tissues181.68 kBAdobe PDFView/Open
Chapter 7.pdfImmunohistochemical study of eutopic human endometrial tissues129.31 kBAdobe PDFView/Open
Chapter 8.pdfImmunohistochemical study of ectopic human endometrial tissues173.76 kBAdobe PDFView/Open
Chapter 9.pdfGeneral Discussion541.31 kBAdobe PDFView/Open
Chapter 10.pdfReferences203.83 kBAdobe PDFView/Open
Colour Page 73.pdfFigure 2.3:A step-by-step sequence of sample preparation and analysis for qRT-PCR 247.43 kBAdobe PDFView/Open
Page 90.pdfFigure 5.1: Immunohistochemical staining of baboon endometrial sections with IKKB. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal24.66 MBAdobe PDFView/Open
Page 91.pdfFigure 5.2: Immunohistochemical staining of baboon endometrial sections with IKBA. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal.16.92 MBAdobe PDFView/Open
Page 92.pdfFigure 5.3: Immunohistochemical staining of baboon endometrial sections with NFKB. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal19.14 MBAdobe PDFView/Open
Page 94.pdfFigure 5.4: Immunohistochemical staining of baboon endometrial sections with Ubiquitin. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal.23.51 MBAdobe PDFView/Open
Page 96.pdfFigure 5.5: Immunohistochemical staining of baboon endometrial sections with TNFA. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal21.44 MBAdobe PDFView/Open
Page 97.pdfFigure 5.6: Immunohistochemical staining of baboon endometrial sections with Proteasome. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal21.18 MBAdobe PDFView/Open
Page 99.pdfFigure 5.7: Immunohistochemical staining of baboon endometrial sections with IKKA. Eutopic endometrium (A) Menses; (B) Late Follicular and (C) Mid-Luteal.21.47 MBAdobe PDFView/Open
Page 106.pdfFigure 6.1: Immunohistochemical staining of baboon endometrial sections with Ubiquitin. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)17.37 MBAdobe PDFView/Open
Page 107.pdfFigure 6.2: Immunohistochemical staining of baboon endometrial sections with TNF-A. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)15.59 MBAdobe PDFView/Open
Page 108.pdfFigure 6.3: Immunohistochemical staining of baboon endometrial sections with IKKB. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)16.15 MBAdobe PDFView/Open
Page 109.pdfFigure 6.4: Immunohistochemical staining of baboon endometrial sections with NFKB. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)14.89 MBAdobe PDFView/Open
Page 111.pdfFigure 6.5: Immunohistochemical staining of baboon endometrial sections with Proteasome. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)15.88 MBAdobe PDFView/Open
Page 113.pdfFigure 6.6: Immunohistochemical staining of baboon endometrial sections with IKBA. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)12.99 MBAdobe PDFView/Open
Page 114.pdfFigure 6.7: Immunohistochemical staining of baboon endometrial sections with IKKA. Mid-Luteal Eutopic endometrium (A) and Ectopic endometrium (B)14.18 MBAdobe PDFView/Open
Page 122.pdfFigure 7.1: Immunohistochemical staining of human endometrial sections with IKKB. Eutopic endometrium (A) Proliferative and (B) Secretory9.65 MBAdobe PDFView/Open
Page 123.pdfFigure 7.2: Immunohistochemical staining of human endometrial sections with IKBA. Eutopic endometrium (A) Proliferative and (B) Secretory10.06 MBAdobe PDFView/Open
Page 125.pdfFigure 7.3: Immunohistochemical staining of human endometrial sections with NFKB. Eutopic endometrium (A) Proliferative and (B) Secretory10.25 MBAdobe PDFView/Open
Page 126.pdfFigure 7.4: Immunohistochemical staining of human endometrial sections with IKKA. Eutopic endometrium (A) Proliferative and (B) Secretory9.52 MBAdobe PDFView/Open
Page 128.pdfFigure 7.5: Immunohistochemical staining of human endometrial sections with Proteasome. Eutopic endometrium (A) Proliferative and (B) Secretory8.97 MBAdobe PDFView/Open
Page 135.pdfFigure 8.1: Immunohistochemical staining of human endometrial sections with IKKB. Proliferative Eutopic endometrium (A) and Ectopic endometrium (B)8.42 MBAdobe PDFView/Open
Page 136.pdfFigure 8.2: Immunohistochemical staining of human endometrial sections with IKKB. Secretory Eutopic endometrium (A) and Ectopic endometrium (B)22.25 MBAdobe PDFView/Open
Page 138.pdfFigure 8.3: Immunohistochemical staining of human endometrial sections with NFKB. Proliferative Eutopic endometrium (A) and Ectopic endometrium (B)9.88 MBAdobe PDFView/Open
Page 139.pdfFigure 8.4: Immunohistochemical staining of human endometrial sections with NFKB. Secretory Eutopic endometrium (A) and Ectopic endometrium (B)11.61 MBAdobe PDFView/Open
Page 141.pdfFigure 8.5: Immunohistochemical staining of human endometrial sections with Proteasome. Proliferative Eutopic endometrium (A) and Ectopic endometrium (B)11.66 MBAdobe PDFView/Open
Page 142.pdfFigure 8.6: Immunohistochemical staining of human endometrial sections with Proteasome. Secretory Eutopic endometrium (A) and Ectopic endometrium (B)10.13 MBAdobe PDFView/Open
Page 144.pdfFigure 8.7: Immunohistochemical staining of human endometrial sections with IKBA. Proliferative Eutopic endometrium (A) and Ectopic endometrium (B).9.29 MBAdobe PDFView/Open
Page 145.pdfFigure 8.8: Immunohistochemical staining of human endometrial sections with IKBA. Secretory Eutopic endometrium (A) and Ectopic endometrium (B)18.03 MBAdobe PDFView/Open
Page 147.pdfFigure 8.9: Immunohistochemical staining of human endometrial sections with IKKA. Proliferative Eutopic endometrium (A) and Ectopic endometrium (B)8.5 MBAdobe PDFView/Open
Page 148.pdfFigure 8.10: Immunohistochemical staining of human endometrial sections with IKKA. Secretory Eutopic endometrium (A) and Ectopic endometrium (B)7.08 MBAdobe PDFView/Open
Appendix 1.1pdf.pdfAppendix 1.1: Drug treatment and procedures for endometriosis52.87 kBAdobe PDFView/Open
Appendix 1.2, 1.3, 1.4, 1.5.pdfAmerican Society of Reproductive Medicine, revised classification of endometriosis; IKKA sequence Conserved helix-loop-helix ubiquitous kinase (CHUK), mRNA; PA28 sequence Homo sapien proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), transcript variant 1, mRNA; NFκβ subunit, p65 sequence Homo sapiens v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA) mRNA288 kBAdobe PDFView/Open

Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.